This is a news article on behalf of the Department of Health and Social Care.
A licensed version of Bisoprolol 5mg/5ml oral solution is now available. Therefore, for prescriptions dispensed in August 2025:
- where there is an endorsement for the licensed product, then reimbursement will be based on Bisoprolol 1mg/ml oral solution sugar free (Aspire Pharma Ltd)
- where there is an endorsement indicating a special was supplied, then reimbursement will be based on the Part VIIIB Drug Tariff price
- where there is no endorsement, then pharmacy contractors will be contacted by the NHS Business Services Authority to confirm what was dispensed and will be reimbursed accordingly
An adjustment will be applied automatically for August 2025 and will appear on the relevant Schedule of Payments.